1. Phase I Clinical Trial of Fibronectin CH296-Stimulated T Cell Therapy in Patients with Advanced Cancer
   Takeshi Ishikawa et al, 2014, PLoS ONE CrossRef
2. Influence of transfusion of lymphokine-activated T killer cells on inflammatory responses in dogs after laparotomy
   Keiichiro MIE et al, 2016, Journal of Veterinary Medical Science CrossRef
3. Whole blood interferon‐γ levels predict the therapeutic effects of adoptive T‐cell therapy in patients with advanced pancreatic cancer
   Takeshi Ishikawa et al, 2013, International Journal of Cancer CrossRef
4. Immune Efficacy and Safety of Fucoidan Extracted from Gagome Kombu (Kjellmaniella crassifolia) in Healthy Japanese Subjects
   Hiromu OHNOGI et al, 2015, Japanese Journal of Complementary and Alternative Medicine CrossRef
5. Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancer
   Takeshi Ishikawa et al, 2018, International Journal of Cancer CrossRef
6. Cell Based Therapy: Modified Cancer Cells
   Vanessa Deschoolmeester et al, 2017, Immunotherapy for Gastrointestinal Cancer CrossRef
7. CD8+ T cell exhaustion and cancer immunotherapy
   Qingda Wang et al, 2023, Cancer Letters CrossRef
8. Change in peripheral blood lymphocyte count in dogs following adoptive immunotherapy using lymphokine-activated T killer cells combined with palliative tumor resection
   Keiichiro Mie et al, 2016, Veterinary Immunology and Immunopathology CrossRef
9. Isatis root polysaccharide promotes maturation and secretory function of monocyte-derived dendritic cells
   Xuebing Wang et al, 2020, BMC Complementary Medicine and Therapies CrossRef
10. Combination of Hyperthermia and Immunotherapy: Hyperthermia and Naïve T-cell Therapy
    Satoshi Kokura, 2016, Hyperthermic Oncology from Bench to Bedside CrossRef